Heidelberg Pharma AG financial statements
Heidelberg Pharma AG's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | EUR 1.46M | EODHD |
| Net income | −EUR 42.28M | EODHD |
| Cash and equivalents | EUR 14.98M | EODHD |
| Total debt | EUR 1.16M | EODHD |
Heidelberg Pharma AG financials on 6ix · Heidelberg Pharma AG on 6ix